Skip to content
Freya Biosciences logo — Driving immune-mediated therapeutic innovation for women.

Freya Biosciences

Driving immune-mediated therapeutic innovation for women.

Founded 2020 Denmark Denmark 27 employees Series A Total: $49.80M Biotechnology, Life Sciences +1

General Information

Company Name Freya Biosciences
Founded Year 2020
Location Denmark Denmark
Founders / Decision Makers
Team member
Employees 27
Industries Biotechnology, Life Sciences, Women's Health
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Freya Biosciences. To contact Freya Biosciences, visit freyabiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Freya Biosciences compare?

A PDF of Freya Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Freya Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Freya Biosciences

Freya Biosciences is a Denmark-based startup that was founded in 2020 with a mission to empower women by providing cutting-edge solutions for improved reproductive health. The company recently secured a substantial $38.00M Series A investment on 12 December 2023, backed by a consortium of prominent investors including Sofinnova Partners, Angelini Ventures, Indaco Venture Partners, OMX Ventures, Export and Investment Fund, CE-Ventures, Mike Jafar Family Office, and Corundum Systems Biology. With its innovative approach and strong financial backing, Freya Biosciences is poised to make a significant impact in the field of reproductive health and women's wellness.

Business keywords: women's health, reproductive health, microbial immunotherapies, clinical-stage, fertility, Copenhagen, Boston

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $11.80M 2
Bill & Melinda Gates Foundation, Export and Investment Fund of Denmark
01 Nov 2024
Series A $38.00M 8
Sofinnova Partners, Angelini Ventures +6
01 Dec 2023

Freya Biosciences Alternatives & Competitors

View All Alternatives
Freya Biosciences vs
Ivy Natal
Ivy Natal United States

Unlocking human fertility. Learn more at https://www.ivynatal.com.

Venture round
4 employees
Biotechnology, Health Care
Freya Biosciences vs
ObsEva SA
ObsEva SA Switzerland

ObsEva. Nature meets Nurture

Post-IPO Debt
9 employees
Biotechnology, Health and Wellness
Freya Biosciences vs
Paterna Biosciences
Paterna Biosciences United States

From infertility to fatherhood

Seed
23 employees
Biotechnology, Health Care

FAQ About Freya Biosciences

Driving immune-mediated therapeutic innovation for women.
Freya Biosciences was founded in 2020.
Freya Biosciences is headquartered in Denmark.
Freya Biosciences operates in Biotechnology, Life Sciences and Women's Health. Its work centres on women's health, reproductive health, microbial immunotherapies and clinical-stage.
Freya Biosciences has approximately 27 employees.
Freya Biosciences has completed 2 funding rounds, raising a total of $49.80M. The latest funding stage is Series A.
Top alternatives and competitors to Freya Biosciences include Ivy Natal, ObsEva SA, Paterna Biosciences, Concerto Biosciences, Notify Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Freya Biosciences and Ivy Natal are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Freya Biosciences, https://bouncewatch.com/company/freya-biosciences, updated 30 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout